We asked Linda de Wit, Technical Practitioner at the Antoni van Leeuwenhoek Hospital in Amsterdam, her view on PALLAS.
‘In the future, the increasing use of existing cancer-specific tracers and the development of innovative tracers will boost the use of medical isotopes. Particularly the demand for therapeutic medical isotopes like lutetium-177 will increase in the years to come.
Globally, there are only a few reactors producing quality medical isotopes. Nuclear practitioners immediately find themselves in trouble if but one of the reactors malfunctions. The importance of the PALLAS-reactor for cancer patients cannot be overestimated.’
Source: Focus on PALLAS